ATOS

Atossa Therapeutics (ATOS)

Atossa Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ATOS
DateTimeSourceHeadlineSymbolCompany
11/24/20219:30AMGlobeNewswire Inc.Registration Is Now Open For The Tribe Public Webinar Event On November 30, 2021 “A Town Hall Q&A Event With Atossa Therapeutics Management Team” NASDAQ:ATOSAtossa Therapeutics Inc
11/15/20219:33AMSeeking AlphaAtossa Therapeutics EPS beats by $0.02 NASDAQ:ATOSAtossa Therapeutics Inc
11/15/20219:31AMEdgar (US Regulatory)Quarterly Report (10-q) NASDAQ:ATOSAtossa Therapeutics Inc
11/15/20219:30AMGlobeNewswire Inc.Atossa Therapeutics Announces Third Quarter 2021 Financial Results and Provides Corporate Update NASDAQ:ATOSAtossa Therapeutics Inc
11/15/20219:26AMEdgar (US Regulatory)Current Report Filing (8-k) NASDAQ:ATOSAtossa Therapeutics Inc
10/21/20219:30AMGlobeNewswire Inc.Atossa Therapeutics CEO Dr. Steven Quay Emphasizes Importance of Breast Cancer Screening During Breast Cancer Awareness Month NASDAQ:ATOSAtossa Therapeutics Inc
10/06/20214:41PMEdgar (US Regulatory)Current Report Filing (8-k) NASDAQ:ATOSAtossa Therapeutics Inc
09/30/20219:30AMGlobeNewswire Inc.Atossa Therapeutics Begins Enrollment in Clinical Study of AT-H201 in Australia NASDAQ:ATOSAtossa Therapeutics Inc
09/10/20211:48PMTipRanks3 Reasons to Love Atossa Therapeutics Stock NASDAQ:ATOSAtossa Therapeutics Inc
09/08/20217:31AMEdgar (US Regulatory)Current Report Filing (8-k) NASDAQ:ATOSAtossa Therapeutics Inc
09/07/20215:20PMGlobeNewswire Inc.Atossa Therapeutics Adjourns Special Stockholder Meeting to October 7, 2021 to Allow Additional Time to Vote NASDAQ:ATOSAtossa Therapeutics Inc
09/02/20219:30AMGlobeNewswire Inc.Atossa Therapeutics Receives Approval from the Swedish Ethics Review Authority to Initiate a Phase 2 Clinical Study of Oral Endoxifen to Reduce Mammographic Breast Density in Sweden NASDAQ:ATOSAtossa Therapeutics Inc
08/17/20211:08PMTipRanksAtossa: Strong Balance Sheet Will Support the Pipeline’s Advance, Says Analyst NASDAQ:ATOSAtossa Therapeutics Inc
08/13/20219:31AMEdgar (US Regulatory)Current Report Filing (8-k) NASDAQ:ATOSAtossa Therapeutics Inc
08/13/20219:30AMGlobeNewswire Inc.Atossa Therapeutics Announces Second Quarter 2021 Financial Results - Provides Corporate Update and Information about Upcoming Stockholder Meeting NASDAQ:ATOSAtossa Therapeutics Inc
08/09/20214:02PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a) NASDAQ:ATOSAtossa Therapeutics Inc
08/05/20219:30AMGlobeNewswire Inc.Atossa Therapeutics to Present at the BTIG Virtual Biotechnology Conference on August 9-10, 2021 NASDAQ:ATOSAtossa Therapeutics Inc
07/31/20214:40PMSeeking AlphaFlora Growth leads weekly healthcare gainers; Alzheimer’s-focused stocks trail NASDAQ:ATOSAtossa Therapeutics Inc
07/30/202111:00AMSeeking AlphaERYTECH Pharma, Allied Healthcare Products leads healthcare gainers; Intec Pharma, Translate Bio among major losers NASDAQ:ATOSAtossa Therapeutics Inc
07/30/20219:51AMSeeking AlphaAtossa loses a tenth after convening a special meeting for shareholders NASDAQ:ATOSAtossa Therapeutics Inc
07/29/20214:03PMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) NASDAQ:ATOSAtossa Therapeutics Inc
07/26/20219:00AMPR Newswire (US)Physician-Scientist Steven Quay: Forensic examination of Wuhan Institute of Virology COVID-19 patient specimens from December 2019 reveals extensive laboratory contamination, including evidence of genetic manipulation of the Nipah Virus, a BSL-4 pathoge... NASDAQ:ATOSAtossa Therapeutics Inc
07/16/202112:10PMSeeking AlphaAtossa in selloff for second straight session after sharp run-up this year NASDAQ:ATOSAtossa Therapeutics Inc
07/15/20219:00AMPR Newswire (US)Physician-Scientist Steven Quay and an International Team of Scientists and Investigators Provide Science-Based Analysis of t... NASDAQ:ATOSAtossa Therapeutics Inc
07/09/202110:54AMTipRanksAtossa’s COVID-19 Treatment Has Potential, Says Analyst NASDAQ:ATOSAtossa Therapeutics Inc
07/07/20214:30PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4) NASDAQ:ATOSAtossa Therapeutics Inc
07/07/20219:50AMSeeking AlphaAtossa Therapeutics gets regulatory nod for AT-H201 COVID-19 study in Australia NASDAQ:ATOSAtossa Therapeutics Inc
07/07/20219:30AMGlobeNewswire Inc.Atossa Therapeutics Receives Regulatory Approval To Open Clinical Study of AT-H201 in Australia NASDAQ:ATOSAtossa Therapeutics Inc
06/29/20218:09PMStockInvest.usHigh volatility in Atossa Genetics Inc. stock price on Tuesday which ended trading at $7.22 NASDAQ:ATOSAtossa Therapeutics Inc
06/29/20218:09PMStockInvest.usHigh volatility in Atossa Genetics Inc. stock price on Tuesday which ended trading at $7.22 NASDAQ:ATOSAtossa Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:ATOS
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20211127 00:08:14